Patient-reported flare frequency is associated with diminished quality of life and family role functioning in systemic lupus erythematosus

被引:15
|
作者
Katz, Patricia [1 ,6 ]
Wan, George J. [2 ]
Daly, Paola [3 ]
Topf, Lauren [3 ]
Connolly-Strong, Erin [2 ,5 ]
Bostic, Ryan [4 ]
Reed, Michael L. [4 ]
机构
[1] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA
[2] Mallinckrodt Pharmaceut, Global Head Hlth Econ & Outcomes Res, Bedminster, NJ USA
[3] Lupus Fdn Amer, Washington, DC USA
[4] Vedanta Res, Chapel Hill, NC USA
[5] Mallinckrodt Pharmaceut, Field Med Affairs, Bedminster, NJ USA
[6] Univ Calif San Francisco, Arthrit Res Grp, 3333 Calif St, San Francisco, CA 94143 USA
关键词
Systemic lupus erythematosus; Flare; Disease activity; Quality of life; Role functioning; DISEASE-ACTIVITY; IMPACT; BURDEN; DAMAGE; PRODUCTIVITY; DISCORDANCE; PREVALENCE; VALIDATION; PREDICTORS; PHYSICIANS;
D O I
10.1007/s11136-020-02572-9
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose To understand the influence of the systemic lupus erythematosus (SLE)-related flares on patient's health-related quality of life (HRQoL). Methods An online survey included individuals with self-reported physician's diagnosis of SLE or lupus nephritis (LN). Lupus impact tracker (LIT) assessed lupus symptoms and HRQoL, SLE-Family questionnaire measured family role functioning, and Healthy Days Core Module (HDCM) measured overall mental and physical health. Chi-square and analysis of variance evaluated differences by flare frequency. Multivariable linear regression and generalized linear models evaluated the independent relationships of flare frequency to HRQoL. Results 1066 respondents with SLE or LN completed the survey. Mean (SD) duration of illness was 12.4 (10.1) years. 93.4% (n = 996) were women, 82.3% (n = 830) were White, and 49.7% (n = 530) were employed or students. More frequent flares were associated with significantly worse scores on all HRQoL measures: LIT (adjusted means: 0 flares, 31.8; 1-3 flares, 47.0; 4-6 flares, 56.1; >= 7 flares, 63.6;P < 0.001); SLE-Family (adjusted means: 0 flares, 3.1; 1-3 flares 3.8; 4-6 flares, 4.3; >= 7 flares, 4.6,P < 0.001); HDCM unhealthy days (0 flares, 8.7; 1-3 flares, 17.4; 4-6 flares, 21.5; >= 7 flares, 26.2 days,P < 0.001). Conclusion Lupus flares contributed to impaired functional and psychological well-being, family functioning, and number of monthly healthy days. Better understanding of the burden of flare activity from the patient's perspective will support a holistic approach to lupus management.
引用
收藏
页码:3251 / 3261
页数:11
相关论文
共 50 条
  • [31] Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies
    Bangert, Elvira
    Wakani, Laura
    Merchant, Mehveen
    Strand, Vibeke
    Touma, Zahi
    PATIENT-RELATED OUTCOME MEASURES, 2019, 10 : 1 - 7
  • [32] Race, ethnicity and patient-reported outcomes in childhood-onset systemic lupus erythematosus
    Borgia, R. E.
    Gurka, M. J.
    Filipp, S. L.
    Elder, M.
    Cardel, M.
    Shiff, N. J.
    CARRA Registry Investigators
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (01) : 186 - 194
  • [33] Possibilities and limits of patient-reported outcome exemplified by systemic lupus erythematosus and the LuLa study
    Chehab, G.
    Richter, J.
    Schneider, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (08): : 698 - 705
  • [34] Association of Baseline Frailty with Patient-Reported Outcomes in Systemic Lupus Erythematosus at 1 Year
    Sarah B. Lieber
    M. Nahid
    M. Rajan
    M. Barbhaiya
    L. Sammaritano
    R. A. Lipschultz
    M. Lin
    M. C. Reid
    L. A. Mandl
    The Journal of Frailty & Aging, 2023, 12 : 247 - 251
  • [35] Quality of Life of Patients with Systemic Lupus Erythematosus (SLE) and Their Family Members
    Jeyalingam, Thurarshen
    Aghdassi, Ellie
    Su, Jiandong
    Wither, Joan
    Clarke, Ann
    Cooper, Glinda
    Rioux, John
    Fortin, Paul R.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1289 - 1290
  • [36] Patient-reported disease impact of systemic lupus erythematosus with active joint symptoms: Results from the systemic lupus erythematosus-update survey
    Kamen, Diane L.
    Birt, Julie A.
    Hadi, Monica A.
    Gibbons, Elizabeth
    Bushnell, Donald M.
    Yu, Ren
    Delbecque, Laure A.
    Griffing, Kirstin
    Askanase, Anca
    LUPUS, 2023, 32 (03) : 342 - 351
  • [37] Predictive validity of Lupus Patient-Reported Outcome for damage accrual in patients with systemic lupus erythematosus: the LUNA Registry
    Nose, Yoko
    Onishi, Akira
    Nishimura, Keisuke
    Yamamoto, Yuzuru
    Sada, Ken-ei
    Ichinose, Kunihiro
    Yoshimi, Ryusuke
    Ohno, Shigeru
    Yanai, Ryo
    Kajiyama, Hiroshi
    Sato, Shuzo
    Shimojima, Yasuhiro
    Fujiwara, Michio
    Kida, Takashi
    Miyawaki, Yoshia
    Matsuo, Yusuke
    Tsuji, Hideaki
    Morinobu, Akio
    Saegusa, Jun
    RHEUMATOLOGY, 2024,
  • [38] Preliminary Evaluation of a Patient-Reported Version for the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI): The Systemic Lupus Erythematosus Disease Activity Questionnaire (SLEDAQ)
    Katz, Patti
    Eudy, Amanda
    Patterson, Sarah
    Rogers, Jennifer
    Pisetsky, David
    Clowse, Megan
    Dall'Era, Maria
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4378 - 4379
  • [39] Using Clinical Characteristics and Patient-Reported Outcome Measures to Categorize Systemic Lupus Erythematosus Subtypes
    Rogers, Jennifer L.
    Eudy, Amanda M.
    Pisetsky, David
    Criscione-Schreiber, Lisa G.
    Sun, Kai
    Doss, Jayanth
    Clowse, Megan E. B.
    ARTHRITIS CARE & RESEARCH, 2021, 73 (03) : 386 - 393
  • [40] Patterns of Patient-reported Outcome Measures in Patients with Systemic Lupus Erythematosus with or Without Concurrent Fibromyalgia
    Gold, Heather
    Li, Yi
    Anthopolos, Rebecca
    Izmirly, Peter
    Buyon, Jill
    Masson, Mala
    Cohen, Brooke
    Barbour, Kamil
    Saxena, Amit
    Belmont, H. Michael
    Tseng, Chung-E
    Corbitt, Kelly
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2547 - 2549